Navigation Links
Epi-Foam Compression Foam, Designed for Post-Operative Liposuction Care, Only from Biodermis
Date:1/17/2013

HENDERSON, Nev., Jan. 17, 2013 /PRNewswire/ -- Epi-Foam is a unique, self-adhering medical grade silicone-backed post-operative compression foam device. It is worn immediately after both traditional and ultra-sonic liposuction procedures and provides a more even compression distribution. Improving compression distribution can assist in smoothing the skin and helping to reduce the "wavering" or "rippling" effect frequently associated with liposuction.  It can also help in reducing post-operative bruising and swelling.

Epi-Foam adheres gently to the skin by using the highest quality medical grade silicone. The adhesion is just enough to keep the pad in place, thus minimizing blistering or shearing.  Furthermore, silicone won't stick to the skin or cause pain and discomfort when removed, as typically experienced when using Reston™.

Unprecedented patient comfort is achieved by using only the most advanced soft, small cell, polyurethane materials to create the compression barrier between the patient's skin and the post-operative garment.  Polyurethane foam also provides for exceptional conformance to three-dimensional contours such as hips, waist, thighs, and chins.

"We believe Epi-Foam post-operative compression pads fill a gap in the post-operative recovery market, providing patients with unmatched comfort, minimized pain, and superior results that are simply not possible with any other product." 
Jeff Schleuning , Ph.D. EVP, Partner, Biodermis 

Each Epi-Foam pad is 7.75" x 11.50" and they are packaged in sets of three.

Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management and post-operative care industry for more than 25 years. For more information regarding Epi-Foam, log on at biodermis.com or call (702) 260-4466.

CONTACT: Sean Mahoney , Biodermis, (702) 260-4466


'/>"/>
SOURCE Biodermis
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
2. Paramedic Designed Auto Rescue Tool is a Top Holiday Gift Pick!
3. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
4. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
5. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
6. BD Launches New Needle Designed to Improve Performance and Patient Comfort
7. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
8. Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV)
9. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
10. Sentara Healthcare, MDLIVE Forge Unique Equity Partnership in Virtual Medicine
11. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Israel , December 5, 2016 ... identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase ... BL-8040, the Company,s leading oncology platform at the ongoing 58th ... San Diego, California . ... , , ...
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... tolerability profile of ropeginterferon alfa-2b versus HU ... long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization in ... this data to the FDA as it seeks approval for ...
(Date:12/4/2016)... HOUSTON , Dec. 3, 2016   Pairnomix, LLC, ... Precision Medicine Alliance (PEPMA) recognized by the White House, today ... individualized approach to the identification of candidate therapies for a ... SCN8A gene were presented at the 70 th ... in Houston, TX , December 2-6, 2016.  ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... it has been featured in SuperbCrew magazine, a leading online tech news platform ... This interview, now featured on SuperbCrew.com, explores the state of enterprise mobility security ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... today that nominations will be accepted from December 5, 2016 through March ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:12/5/2016)... ... December 05, 2016 , ... Researchers at Johns Hopkins All ... brains of young athletes. Over the course of three years, researchers will study concussions ... guards. The mouth guards, equipped with special sensors, will track the location and force ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ®, a leading ... firm kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise ... licensing agreement three years ago to design and develop the kathy ireland® Loved ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy Awareness,” which can be ... sparks a conversation about epilepsy, bearing down on the social stigma and lack ... diagnosed with epilepsy within their lifetime. With such a large percentage of people ...
Breaking Medicine News(10 mins):